Stonepine Capital Management, LLC Vir Biotechnology, Inc. Transaction History
Stonepine Capital Management, LLC
- $123 Billion
- Q3 2025
A detailed history of Stonepine Capital Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 160,000 shares of VIR stock, worth $900,800. This represents 0.74% of its overall portfolio holdings.
Number of Shares
160,000
Previous 130,000
23.08%
Holding current value
$900,800
Previous $655 Million
39.44%
% of portfolio
0.74%
Previous 0.64%
Shares
4 transactions
Others Institutions Holding VIR
# of Institutions
243Shares Held
106MCall Options Held
246KPut Options Held
126K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$93.9 Million0.72% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$92.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$72.7 Million32.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$72.1 Million0.0% of portfolio
-
State Street Corp Boston, MA5.24MShares$29.5 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $747M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...